E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/5/2020 in the Prospect News Convertibles Daily.

New Issue: NanoString prices upsized $200 million 2.625% convertible notes due 2025, up 40%

By Abigail W. Adams

Portland, Me., March 5 – NanoString Technologies Inc. priced an upsized $200 million of five-year convertible notes after the market close on Wednesday at par with a coupon of 2.625% and an initial conversion premium of 40%, according to a company news release.

Pricing came at the midpoint of talk for a coupon of 2.375% to 2.875% and an initial conversion premium of 37.5% to 42.5%, according to a market source.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC were bookrunners for the Rule 144A offering, which carries an upsized greenshoe of $30 million.

The initial size of the deal was $175 million with a greenshoe of $26.25 million.

The notes are contingently convertible until Dec. 1, 2024.

They are non-callable until March 5, 2023 and then subject to a 130% hurdle with a make-whole.

The notes are putable upon a fundamental change.

Net proceeds are expected to be $193.5 million, or $222.6 million if the greenshoe is exercised in full.

Approximately $89 million of the proceeds will be used to terminate the company’s senior term loan facility.

Remaining proceeds will be used for general corporate purposes, including the continued development of its GeoMx Digital Spatial Profiling system, the commercialization of its nCounter-based products and for working capital.

NanoString Technologies is a Seattle-based biotech company specializing in cancer diagnostic tools.

Issuer:NanoString Technologies Inc.
Securities:Convertible senior notes
Amount:$200 million
Greenshoe:$30 million
Maturity:March 1, 2025
Bookrunners:J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
Co-managers:Robert W. Baird & Co. Inc., Stifel, Nicolaus & Co., Inc. and UBS Securities LLC
Coupon:2.625%
Price:Par
Yield:2.625%
Conversion premium:40%
Conversion price:$47.81
Conversion rate:20.9161
Call options:Non-callable until March 5, 2023 and then subject to a 130% hurdle with a make-whole
Put options:Upon a fundamental change
Pricing date:March 4
Settlement date:March 9
Distribution:Rule 144A
Talk:Coupon of 2.375% to 2.875% and initial conversion premium of 37.5% to 42.5%
Stock symbol:Nasdaq: NSTG
Stock price:$34.15 at market close March 4
Market capitalization:$1.26 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.